Alcon Introduces New LenSx® SoftFit™ Patient Interface
Nov 08, 2012
New LenSx® SoftFit™ Patient Interface provides surgeons advancements that promote easier docking, free floating capsulotomies, lower IOP, and improved surgical performance.
LenSx® Laser platform continues to lead in refractive cataract surgery innovation and patient comfort.
FORT WORTH, Texas, November 8, 2012 – Alcon announced today its latest release in its series of innovation within the LenSx® Laser platform, the LenSx® SoftFit™ Patient Interface. The new patient interface enables surgeons to improve surgical performance and deliver enhanced patient comfort.
The LenSx® SoftFit™ Patient Interface, which provides all the features of the LenSx® Laser single piece patient interface, offers a proprietary soft contact lens technology that enables the natural curvature of the cornea to conform to a soft contact lens insert. This allows a secure and gentle fit to a patient’s eye while minimizing corneal distortion. The LenSx® SoftFit™ Patient Interface delivers:
Free floating capsulotomy in nearly all cases
Pristine capsulotomy edges
Enhanced patient comfort
Lower IOP rise of 16mmHg
Improved surgical performance with a 66 percent reduction in energy to the eye
Procedure time reduced by 34 percent
"In my opinion, the new patient interface is the most significant advancement for Alcon’s LenSx® Laser platform since the introduction of the laser itself,” said Stephen Slade, MD, of the Slade & Baker Vision Center located in Houston, Texas. “Every aspect of the surgery: free floating capsulotomies, lens chops, lower IOP, corneal incisions, patient comfort, reduced energy and speed, are all taken up to an entirely new level with the new LenSx® SoftFit™ Patient Interface." This new offering furthers Alcon’s commitment to providing surgeons new innovation in laser refractive cataract surgery. The company plans to introduce and demonstrate the LenSx® SoftFit™ Patient Interface at the November 10 – 13 American Academy of Ophthalmology Joint Meeting in Chicago, Ill. Those surgeons attending the conference are encouraged to visit the Alcon tradeshow booth No. 2808, to learn more about this new LenSx® Laser advancement.
“We are very pleased to further expand our LenSx® Laser platform with the new LenSx® SoftFit™ Patient Interface,” said Laurent Attias, Head of Global Commercial Strategy, Alcon. “We believe this represents an important step forward within the refractive cataract market, and further differentiates the capabilities and technologies we offer surgeons through our LenSx® Laser platform.”
The new LenSx® SoftFit™ Patient Interface will become available in most markets by the end of 2012.
About Alcon Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. The three Alcon businesses - Surgical, Pharmaceutical and Vision Care - offer the widest spectrum of eye care products in the world. Alcon is the second largest division of the Novartis Group with pro-forma sales of USD 10 billion in 2011. Headquartered in Fort Worth, Texas, U.S.A., Alcon has 24,000 employees worldwide, operations in 75 countries and products available in 180 markets. For more information, visit www.alcon.com.
For more information about the LenSx® Laser please refer to the accompanying important safety information.
Caution: United States Federal Law restricts this device to sale and use by or on the order of a physician or licensed eye care practitioner. Indication: The LenSx® Laser is indicated for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, phacofragmentation, and the creation of single plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure. Restrictions: • Patients must be able to lie flat and motionless in a supine position. • Patient must be able to understand and give an informed consent. • Patients must be able to tolerate local or topical anesthesia. • Patients with elevated IOP should use topical steroids only under close medical supervision. Contraindications: • Corneal disease that precludes applanation of the cornea or transmission of laser light at 1030 nm wavelength • Descemetocele with impending corneal rupture • Presence of blood or other material in the anterior chamber • Poorly dilating pupil, such that the iris is not peripheral to the intended diameter for the capsulotomy • Conditions which would cause inadequate clearance between the intended capsulotomy depth and the endothelium (applicable to capsulotomy only) • Previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape • Corneal thickness requirements that are beyond the range of the system • Corneal opacity that would interfere with the laser beam • Hypotony, glaucoma, or the presence of a corneal implant • Residual, recurrent, active ocular or eyelid disease, including any corneal abnormality (for example, recurrent corneal erosion, severe basement membrane disease) • This device is not intended for use in pediatric surgery • A history of lens with zonular instability. • Any contraindication to cataract or keratoplasty surgery. Attention: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions. Warnings: The LenSx® Laser System should only be operated by a physician trained in its use. The LenSx® Laser delivery system employs one sterile disposable LenSx® Laser Patient Interface consisting of an applanation lens and suction ring. The Patient Interface is intended for single use only. The disposables used in conjunction with ALCON® instrument products constitute a complete surgical system. Use of disposables other than those manufactured by Alcon may affect system performance and create potential hazards. The physician should base patient selection criteria on professional experience, published literature, and educational courses. Adult patients should be scheduled to undergo cataract extraction. Precautions: • Do not use cell phones or pagers of any kind in the same room as the LenSx® Laser. • Discard used Patient Interfaces as medical waste. AEs/Complications: • Capsulotomy, phacofragmentation, or cut or incision decentration • Incomplete or interrupted capsulotomy, fragmentation, or corneal incision procedure • Capsular tear • Corneal abrasion or defect • Pain • Infection • Bleeding • Damage to intraocular structures • Anterior chamber fluid leakage, anterior chamber collapse • Elevated pressure to the eye